Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanessa Innao

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Blood Cells, Molecules & Diseases|November 20, 2016
Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cellsAlessandro Allegra, Vanessa Innao, Demetrio Gerace, et al.
Case Reports in Hematology|June 16, 2023
Two Refractory Immune Thrombocytopenia Case Reports Showing Responsiveness to FostamatinibVanessa Innao, Rosalba Donatella Calogero, Fabrizio Lo Presti, et al.
European Journal of Cancer Care|January 4, 2020
Therapeutic potential of antagomiRs in haematological and oncological neoplasmsVanessa Innao, Alessandro Allegra, Nicolina Pulvirenti, et al.
Current Oncology (Toronto, Ont.)|March 11, 2021
Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy DrugsVanessa Innao, Vincenzo Rizzo, Andrea Gaetano Allegra, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 24, 2019
Selective Inhibitors of Nuclear Export in the Treatment of Hematologic MalignanciesAlessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 5, 2021
Immune thrombocytopenia: options and new perspectivesSantino Caserta, Anna Maria Zaccuri, Vanessa Innao, et al.
Cells|March 6, 2021
Promising Anti-Mitochondrial Agents for Overcoming Acquired Drug Resistance in Multiple MyelomaVanessa Innao, Vincenzo Rizzo, Andrea Gaetano Allegra, et al.
Antioxidants (Basel, Switzerland)|November 17, 2020
Radioprotective Agents and Enhancers Factors. Preventive and Therapeutic Strategies for Oxidative Induced Radiotherapy Damages in Hematological MalignanciesAndrea Gaetano Allegra, Federica Mannino, Vanessa Innao, et al.
Pharmacology & Therapeutics|September 16, 2017
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myelomaRoberta Ettari, Maria Zappalà, Silvana Grasso, et al.
Cancer Investigation|December 21, 2016
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical StudiesAlessandro Allegra, Vanessa Innao, Sabina Russo, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Blood Cells, Molecules & Diseases|November 20, 2016
Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cellsAlessandro Allegra, Vanessa Innao, Demetrio Gerace, et al.
Case Reports in Hematology|June 16, 2023
Two Refractory Immune Thrombocytopenia Case Reports Showing Responsiveness to FostamatinibVanessa Innao, Rosalba Donatella Calogero, Fabrizio Lo Presti, et al.
European Journal of Cancer Care|January 4, 2020
Therapeutic potential of antagomiRs in haematological and oncological neoplasmsVanessa Innao, Alessandro Allegra, Nicolina Pulvirenti, et al.
Current Oncology (Toronto, Ont.)|March 11, 2021
Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy DrugsVanessa Innao, Vincenzo Rizzo, Andrea Gaetano Allegra, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 24, 2019
Selective Inhibitors of Nuclear Export in the Treatment of Hematologic MalignanciesAlessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 5, 2021
Immune thrombocytopenia: options and new perspectivesSantino Caserta, Anna Maria Zaccuri, Vanessa Innao, et al.
Cells|March 6, 2021
Promising Anti-Mitochondrial Agents for Overcoming Acquired Drug Resistance in Multiple MyelomaVanessa Innao, Vincenzo Rizzo, Andrea Gaetano Allegra, et al.
Antioxidants (Basel, Switzerland)|November 17, 2020
Radioprotective Agents and Enhancers Factors. Preventive and Therapeutic Strategies for Oxidative Induced Radiotherapy Damages in Hematological MalignanciesAndrea Gaetano Allegra, Federica Mannino, Vanessa Innao, et al.
Pharmacology & Therapeutics|September 16, 2017
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myelomaRoberta Ettari, Maria Zappalà, Silvana Grasso, et al.
Cancer Investigation|December 21, 2016
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical StudiesAlessandro Allegra, Vanessa Innao, Sabina Russo, et al.
Pageof 7